Á lódáil...
Satralizumab: First Approval
Satralizumab (Enspryng(®)), a humanized anti-interleukin-6 (IL-6) receptor monoclonal recycling antibody, has been developed by Chugai Pharmaceutical and Roche for the treatment of neuromyelitis optica spectrum disorder (NMOSD). In June 2020, based on positive results from two pivotal phase III tria...
Na minha lista:
| Foilsithe in: | Drugs |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Springer International Publishing
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7522096/ https://ncbi.nlm.nih.gov/pubmed/32797372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01380-2 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|